ProteoMediX

Healthcare 📍 Schlieren, Switzerland 👥 201-500 employees 💰 $7.1M raised 📅 Founded 2010

ProteoMediX is a spinoff company of ETH Zurich and specialized in the identification of novel biomarkers for the early detection of cancer and the personalized treatment thereof. The first product currently developed is a blood-based test that enables the diagnosis of prostate cancer with significantly higher accuracy

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Healthcare

Country

Switzerland

Employees

201-500

Total Raised · Venture

$7.1M

Founded

2010

Cloud

Unknown

Email

Microsoft 365

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	Microsoft 365
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$1M – $3M / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	Google Analytics HubSpot
CMS / Platform	HubSpot CMS
Frontend Stack	🔒 Subscribers only

Detected from ProteoMediX's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Mylan Specialty

201-500 ☁️ AWS

201-500 ☁️ Cloudflare

Park Hotels & Resorts

51-200 ☁️ Unknown

Data detected 2026-06-13 · Methodology · Suggest a correction